Waters Corporation

NYSE WAT

Data sourced from

and

Download Data

Waters Corporation Days Payable Outstanding (DPO) 1 year YoY Change (%) for the year ending December 31, 2023: -5.19%

Waters Corporation Days Payable Outstanding (DPO) 1 year YoY Change (%) is -5.19% for the year ending December 31, 2023, a 51.44% change year over year. The days payables outstanding ratio measures the average number of days it takes for a company to pay its suppliers. It is calculated by dividing accounts payable by the cost of revenue and then multiplying by 365. This ratio indicates the average payment period for suppliers and reflects the efficiency of managing trade payables. A longer period suggests extended payment terms and potential working capital advantages. The measure "Change (%)" refers to the percentage change in the value of a financial metric between two time points. This measure provides a relative perspective on the magnitude of change.

Waters Corporation Days Payable Outstanding (DPO) for the year ending December 31, 2022 was 27.28, a -10.69% change year over year.
Waters Corporation Days Payable Outstanding (DPO) for the year ending December 31, 2021 was 30.55, a 16.68% change year over year.
Waters Corporation Days Payable Outstanding (DPO) for the year ending December 31, 2020 was 26.18, a 47.96% change year over year.
Waters Corporation Days Payable Outstanding (DPO) for the year ending December 31, 2019 was 17.70, a -29.41% change year over year.

NYSE: WAT

Waters Corporation

CEO	Dr. Udit Batra Ph.D.
IPO Date	Nov. 16, 1995
Location	United States
Headquarters	34 Maple Street, Milford, MA, United States, 01757
Employees	7,900
Sector	Healthcare
Industry	Diagnostics & research

Description

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans. It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. In addition, the company offers MS technology instruments are used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. Further, the company provides thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer good, and healthcare products, as well as for life science research. Its products are used by clinical, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. The company was founded in 1958 and is headquartered in Milford, Massachusetts.

Key trends